Prostate radiotherapy clinical trial quality assurance: How real should real time review be? (A TROG-OCOG Intergroup Project)

Radiotherapy and Oncology

Volumn 107, Issue 3, 2013, Pages 333-338

  Martin, Jarad ^a   Frantzis, Jim ^b   Chung, Peter ^c   Langah, Ijaz ^b   Crain, Melissa ^d   Cornes, Deidre ^d   Plank, Ash ^b   Finch, Terri ^e   Jones, Mark ^b   Khoo, Eric ^b   Catton, Charles ^c  

^a CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^b Toowoomba Specialist Centre   (Australia)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d Trans Tasman Radiation Oncology Group   (Australia)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

Clinical trial; Prostate neoplasm; Quality assurance; Radiotherapy

Indexed keywords

ADULT; AGED; AUSTRALIA; CANADA; CANCER RADIOTHERAPY; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; RANDOMIZATION; REAL TIME REVIEW; REVIEW;

CLINICAL TRIAL; PROSTATE NEOPLASM; QUALITY ASSURANCE; RADIOTHERAPY;

HUMANS; MALE; PROSTATIC NEOPLASMS; QUALITY ASSURANCE, HEALTH CARE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TUMOR BURDEN;

EID: 84881480103     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.05.015     Document Type: Article

References (22)

1. J.M. Martin, J. Frantzis, T. Eade, and P. Chung Clinician's guide to prostate IMRT plan assessment and optimisation J Med Imaging Radiat Oncol 54 2010 569 575
2. L.J. Peters, B. O'Sullivan, and J. Giralt Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02 J Clin Oncol 28 2010 2996 3001
3. E.L. Khoo, K. Schick, and A.W. Plank Prostate contouring variation: can it be fixed? Int J Radiat Oncol Biol Phys 8 5 2012 1923 1929
4. R.P. Muller, and H.T. Eich The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel Strahlenther Onkol 181 2005 557 566
5. J.A. Martenson Jr., R. Urias, and S.R. Smalley Radiation therapy quality control in a clinical trial of adjuvant postoperative treatment for rectal cancer Int J Radiat Oncol Biol Phys 32 1995 51 55
6. J.M. Martin, A. Bayley, and R. Bristow Image guided dose escalated prostate radiotherapy: still room to improve Radiat Oncol 4 2009 50
7. J.M. Martin, T. Rosewall, and A. Bayley Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma Int J Radiat Oncol Biol Phys 69 2007 1084 1089
8. D.C. Weber, P.M. Poortmans, C.W. Hurkmans, E. Aird, A. Gulyban, and A. Fairchild Quality assurance for prospective EORTC radiation oncology trials: the challenges of advanced technology in a multicenter international setting Radiother Oncol 100 2011 150 156
9. M. Middleton, J. Frantzis, and B. Healy Successful implementation of image-guided radiation therapy quality assurance in the Trans Tasman radiation oncology group 08.01 PROFIT study Int J Radiat Oncol Biol Phys 81 2011 1576 1581
10. B. Healy, J. Frantzis, and R. Murry Development of a dosimetry inter-comparison for IMRT as part of site credentialing for a TROG multi-centre clinical trial for prostate cancer Australas Phys Eng Sci Med 34 2011 195 202
11. A.L. Zietman, K. Bae, and J.D. Slater Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/American college of radiology 95-09 J Clin Oncol 28 2010 1106 1111
12. D.A. Kuban, S.L. Tucker, and L. Dong Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 2008 67 74
13. A. Fairchild, L. Collette, and C.W. Hurkmans Do results of the EORTC dummy run predict quality of radiotherapy delivered within multicentre clinical trials? Eur J Cancer 48 2012 3232 3239
14. K. Dieckmann, R. Potter, and W. Wagner Up-front centralized data review and individualized treatment proposals in a multicenter pediatric Hodgkin's disease trial with 71 participating hospitals: the experience of the German-Austrian pediatric multicenter trial DAL-HD-90 Radiother Oncol 62 2002 191 200
15. H. Nielsen, J. Overgaard, C. Grau, J. Christensen, and M. Overgaard Audit of the radiotherapy in the DBCG 82 b&c trials - a validation study of the 1538 patients randomised to postmastectomy radiotherapy Radiother Oncol 76 2005 285 292
16. C. Carrie, S. Hoffstetter, and F. Gomez Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP) Int J Radiat Oncol Biol Phys 45 1999 435 439
17. C. Carrie, X. Muracciole, and F. Gomez Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol Int J Radiat Oncol Biol Phys 63 2005 711 716
18. J.M. Michalski, H. Gay, A. Jackson, S.L. Tucker, and J.O. Deasy Radiation dose-volume effects in radiation-induced rectal injury Int J Radiat Oncol Biol Phys 76 2010 S123 S129
19. Prescribing, recording and reporting IMRT: ICRU report 83. Definition of volumes J ICRU 10 2010 41 53
20. T.J. FitzGerald, M. Urie, and K. Ulin Processes for quality improvements in radiation oncology clinical trials Int J Radiat Oncol Biol Phys 71 2008 S76 S79
21. N. Bhandare, A. Jackson, and A. Eisbruch Radiation therapy and hearing loss Int J Radiat Oncol Biol Phys 76 2010 S50 S57
22. T.J. FitzGerald, M. Bishop-Jodoin, and M.G. Cicchetti Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Oncol Biol Phys 2009;73:492-498) Int J Radiat Oncol Biol Phys 77 2010 315 316